STOCK ALERT: Rosen Law Firm Reminds TerraForm Global, Inc.

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
STOCK ALERT: Rosen Law Firm Reminds TerraForm Global, Inc. Investors of Important December 28, 2015 Deadline in Class Action - GLBL

NEW YORK, Dec. 10, 2015 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of TerraForm Global, Inc. (NASDAQ: GLBL ) securities pursuant and/or traceable to the Registration Statement and Prospectus issued in connection with TerraForm’s July 31, 2015 initial public stock offering (“IPO”) of the important December 28, 2015 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for TerraForm investors under the federal securities laws.

To join the TerraForm class action, go to the firm’s website at http://rosenlegal.com/cases-721.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com for information on the class action.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.

The Complaint alleges that Defendants failed to disclose material information in its Registration Statement, including failure to disclose that by the time of the IPO: (1) the IPO sponsor SunEdison was experiencing unprecedented losses that would be revealed just days after the finalization of the IPO; (2) SunEdison was experiencing liquidity and debt issues that ended its ability to develop projects to sell to TerraForm; thus, TerraForm’s “Yield Co” business model was effectively moribund from the outset; and (3) the aggressive growth plans for SunEdison and TerraForm were unachievable. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 28, 2015. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to the firm’s website at http://rosenlegal.com/cases-721.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com .

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Attorney Advertising.  Prior results do not guarantee a similar outcome.

Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 34th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 lrosen@rosenlegal.com pkim@rosenlegal.com www.rosenlegal.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Spotting Roof Leaks: Avoid Costly Repairs Before Rains

Updated Category News Views 45

Identify Roof Troubles Before They Soak You The first trick is recognizing the sneaky signs of a roof leak before a downpour turns a small problem into an expensive headache. Rain might not be knocking just yet, but if your roof's hiding trouble, you'll want to catch it before it gets stormy. That's where Ryan Gonzales, residential roofing expert and owner of Ascend...

Continue Reading
Ryan Nowicki Strengthens Crowell & Moring's Tax Group

Updated Category News Views 59

Major Addition to Crowell & Moring's Team When it comes to law firms beefing up their rosters, Crowell & Moring's snagging Ryan Nowicki is quite the catch. Announced on November 11, 2026, the firm added this tax guru to their Los Angeles Tax Group. With over 20 years under his belt, advising private entities and the crème de la crème among high-net-worth folks,...

Continue Reading
Clarivate's Upcoming Conference Presentation: What to Expect

Updated Category News Views 24

Conference Time: Will Clarivate Deliver the Goods? Grab your calendars, folks. November 18 is when Clarivate Plc is stepping into the spotlight at the RBC Capital Markets Global Technology, Internet, Media and Telecommunications Conference. Their bigwigs, Matti Shem Tov, the CEO, and Michael Easton, the CFO, will be there to spill the beans. They’re set to take the mike...

Continue Reading
Coastal Financial Faces Crisis as Lawsuit Deadline Looms

Updated Category News Views 50

Coastal Financial Caught in a Storm Folks are buzzing about the drama unraveling around Coastal Financial (NASDAQ:CCB), and it's not for good reasons. Shares nose-dived a jaw-dropping 43.52%, leaving investors feeling like they got hit by a freight train. The culprit? A messy soup of financial woes and alleged misinformation. A Deep Dive into the Numbers Let's rip the...

Continue Reading
AI Shakes Up Boat Discovery: Traffic Soars for Leaders

Updated Category News Views 28

AI's Surge in the Boating World Well, look who’s riding the AI wave—it's our old friends at Boat Trader and YachtWorld, leaving the competition coughing in their slipstream. Similarweb data throws some cold, hard fish onto the deck, showing these two raking in over 17 times the AI-referred traffic compared to their closest peers. If you’re sniffing around for where...

Continue Reading
Cooper's Heat Pump Campaign Fuels Denver's Community

Updated Category News Views 124

How Heat Pumps Meet Philanthropy in Denver Alright, let me lay it out for you—a story as much about ingenuity as generosity. Cooper Heating & Cooling, donning their ‘Cooper Green Team’ capes, just wrapped up one heck of a community-driven campaign. They dropped a cool $5,000 into the coffers of We Don't Waste, a Denver nonprofit focused on food recovery. This...

Continue Reading
Taiwan's Bubble Tea Maker Shines in Sustainability Focus

Updated Category News Views 56

A Bubble Tea Brand Making Sustainable Waves Not many would imagine a bubble tea company shaking up the sustainability scene, but Empire Eagle Food Co. has done just that. Right from a rice field in Chishang, Taitung, once as silent as a whisper, four remarkable species made a comeback, and so did hope. The crested serpent eagle and pangolin alongside other wildlife became...

Continue Reading
Vylor's 2026 Guidance Reaffirmation Bolsters Confidence

Updated Category News Views 15

Vylor's Resilient Outlook Amid Strong Year-To-Date Performance Vylor Inc. (NYSE: VYLR) is singing a tune of resilience and calculated ambition after shedding the weight of a tough quarter by doubling down on its full-year guidance for 2026. It ain't exactly smooth sailing, with the waters getting a bit choppy, but this ship seems sturdy enough to stay on course. Numbers...

Continue Reading
QFIN Lawsuit: Executives Face Control Liability

Updated Category News Views 82

QFIN Executives in Legal Hot Water Qfin Holdings, Inc. (NASDAQ: QFIN) is in a tight spot as a securities class action lawsuit casts a harsh spotlight on its senior executives. The CEO and CFO, during the contested class period, are front and center in this legal tangle. Qfin's stockholders are grappling with losses, and it's all tied back to some certified SEC filings...

Continue Reading
McKinley Irvin Adds Veteran Willa Staats to Legal Team

Updated Category News Views 73

New Talent Joins a Leading Family Law Firm Some folks think of family law as just another branch of the legal world, but let's be real—it's where emotions run high and stakes can catch you off guard like a sudden market downturn. So, when McKinley Irvin, one of the Pacific Northwest’s top family law outfits, brings someone new aboard, that’s worth putting under the...

Continue Reading

Top 5 Most Recently Viewed Articles

Twilio's Q4 Results Spark Diverse Analyst Reactions

Updated Category News Views 232

Twilio Inc Fourth Quarter Overview Twilio Inc reported notable financial results for the fourth quarter, capturing the attention of several analysts within the market. The company’s performance has sparked diverse reactions, particularly regarding its future guidance and the evolving role of artificial intelligence within its operations. Market Response to Q4 Earnings...

Continue Reading
FHLBank Indianapolis Dividends for Second Quarter of 2025

Updated Category News Views 180

FHLBank Indianapolis Declares Second Quarter Dividends FHLBank Indianapolis recently announced its second quarter dividends for 2025, detailing robust financial strategies and growth, as reflected in the declared dividends on Class B-2 activity-based capital stock and Class B-1 non-activity-based stock. These dividends have been set at annualized rates of 9.50% and 4.50%,...

Continue Reading
Neurogen Biomarking Partners with Quanterix for Alzheimer's Testing

Updated Category News Views 255

Revolutionizing Alzheimer's Detection with Neurogen Biomarking Neurogen Biomarking is making significant strides in the healthcare landscape by introducing a pioneering blood test aimed at the early detection of Alzheimer's disease and Mild Cognitive Impairment (MCI). This innovative approach leverages advanced biomarker technology developed by Quanterix Corporation,...

Continue Reading
Kepler Robotics Launches Innovative Humanoid Robot for Industries

Updated Category News Views 296

Revolutionizing Industries with the K2 Bumblebee Shanghai Kepler Robotics Co., Ltd has excitedly announced the commencement of mass production of its K2 "Bumblebee" model, confirming that the world's first commercially available hybrid-architecture humanoid robot is now shipping to eager customers. Milestone in Humanoid Robotics This significant development not only marks...

Continue Reading
Syntara Limited Reveals Groundbreaking Data in Myelofibrosis Trials

Updated Category News Views 259

Positive Interim Data from Syntara's Clinical Trials Syntara Limited, known for its innovative approach in drug development, has unveiled promising interim data concerning its ongoing Phase 2 study of SNT-5505. This clinical trial focuses on myelofibrosis, a complex bone marrow disorder that often leads to severe health complications. Details of the Clinical Trial The...

Continue Reading